Human Vaccines & Immunotherapeutics
Volume 20, 2024 - Issue 1
Rotavirus
Health economic evaluation of 2-dose and 3-dose rotavirus vaccines in children below 5 years of age in Morocco
Ahmed Mohya Value Evidence & Outcomes Emerging Markets, GSK, Wavre, BelgiumCorrespondence[email protected]
https://orcid.org/0000-0002-4605-8254View further author information
https://orcid.org/0000-0002-4605-8254View further author information, Youness Lagoubib Vaccines Emerging Markets, GSK, Casablanca, Moroccohttps://orcid.org/0000-0002-4153-1647View further author information
https://orcid.org/0000-0002-4153-1647View further author information, Jorge A. Gomezc Vaccines, Emerging Markets, GSK, Buenos Aires, Argentinahttps://orcid.org/0000-0001-5459-4973View further author information
https://orcid.org/0000-0001-5459-4973View further author information, Barry Amadoub Vaccines Emerging Markets, GSK, Casablanca, Moroccohttps://orcid.org/0000-0002-8942-8956View further author information
https://orcid.org/0000-0002-8942-8956View further author information & 